Boron Molecular and HH&W Partners Announce Exclusive Flow Chemistry Agreement

Boron Molecular and HH&W Partners are pleased to announce the signing of an exclusive agreement to collaborate on the development of commercial scale flow-chemistry based drug manufacture in Australia. Having answered the question ‘Can we guarantee supply of essential drugs in a global crisis’, Boron Molecular will apply the technical expertise generated through the Proof …

Boron Molecular and HH&W Partners Announce Exclusive Flow Chemistry Agreement Read More »